Study links mutations in protein to rare blood vessel condition

07/23/2009 | U.S. News & World Report

Canadian researchers said they identified genetic variations in thrombomodulin, a protein that plays a role in blood coagulation and preventing cell damage, that appear to increase the risk of atypical hemolytic-uremic syndrome. The findings could pave the way for treatments for aHUS, a rare blood vessel disorder caused by damage to endothelial cells, the lead researcher said.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA